Nuvectis Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $22,897,000.
Profit Margin
| 2020 | 0 | -10K | |
|---|---|---|---|
| 2021 | 0 | -12.88M | |
| 2022 | 149K | -18.78M | -12608.72% |
| 2023 | 0 | -22.26M |
NVCT Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 149K | 0 | 0 |
Cost of revenue | 22.89M | 19.23M | 12.89M | 0 |
Gross profit | -22.89M | -19.08M | -12.89M | 0 |
Operating exp. | ||||
Research and development | 15.38M | 13.22M | 9.54M | 0 |
Selling and marketing | 14K | 0 | 0 | 9.97K |
Total operating expenses | 22.89M | 19.23M | 12.89M | 10K |
Operating income | -22.89M | -19.23M | -12.89M | -10K |
Other income (expenses), net | 637K | 149K | 4K | 14K |
Income before tax | -22.26M | -19.08M | -12.89M | -10K |
Income tax expense | 0 | -298K | -4K | -24 |
Net income | -22.26M | -18.78M | -12.88M | -10K |
Earnings per share | ||||
Basic EPS | -1.43 | -1.48 | -1.01 | -0.00 |
Diluted EPS | -1.43 | -1.48 | -1.01 | -0.00 |
| Data source | Data source | Data source |